Am J Transplant, Volume 20, Suppl 3 Archives - Page 199 of 223 - ATC Abstracts

2020 American Transplant Congress
The Prevalence of Preemptive Transplantation at a Large Volume Kidney Transplant Center
T. Menser¹, M. J. Hobeika², S. G. Yi², T. Nisar¹, A. Gaber²
¹Houston Methodist Research Institute, Houston, TX, ²Houston Methodist Hospital, Houston, TX
*Purpose: In the wake of the Executive Order on Advancing American Kidney Health, it is essential to fully examine the current care paradigm for chronic…
2020 American Transplant Congress
Outcome of Trans-Umbilical Single Port Laparoscopic Donor Nephrectomy
D. Lia, Y. Alsalmay, L. Teperman, E. Grodstein, L. Lau, E. Molmenti, A. Fahmy
Surgery, Northshore-LIJ, Manhasset, NY
*Purpose: To evaluate the safety, efficacy, and outcomes of trans-umbilical single port laparoscopic donor nephrectomy (SPLDN).*Methods: We performed a retrospective review of 100 SPLDNs between…
2020 American Transplant Congress
Organ Offer Behavioral Research Enhances Transplant Surgeon Training
T. S. Diwan¹, D. Stewart², K. Lindblad², A. Dick³, R. Hirose⁴, L. Ratner⁵
¹Univ of Cincinnati Med Ctr, Cincinnati, OH, ²United Network for Organ Sharing, Richmond, VA, ³Seattle Children's Hospital, Seattle, WA, ⁴UCSF Health, San Francisco, CA, ⁵Columbia Univ/NY Pres Hosp, New York, NY
*Purpose: Due to the complexities of fielding organ offers, the 2019 ASTS 2nd Year Surgical Fellows Symposium’s agenda included multiple sessions devoted to training on…
2020 American Transplant Congress
Efficacy and Safety Outcomes by Donor Type in De Novo Renal Transplant Recipients Receiving Everolimus with Reduced-Dose Calcineurin Inhibitor: 24-Month Results from Transform
S. Berger¹, M. Bakr¹, F. Bemelman¹, R. Danguilan¹, H. De Fijter¹, D. Han¹, M. Kim¹, E. Mor¹, A. Patel¹, M. Hernandez Gutierrez², A. Gawai², Y. Watarai¹
¹TRANSFORM Study Group, Basel, Switzerland, ²Novartis Pharma AG, Basel, Switzerland
*Purpose: To assess the efficacy and safety outcomes in de novo renal transplant (RTx) recipients receiving everolimus with reduced-exposure calcineurin inhibitor (EVR+rCNI) versus mycophenolate with…
2020 American Transplant Congress
Chronic Active T-Cell Mediated Rejection is Variably Responsive to Immunosuppressive Therapy
V. Kung¹, M. Haas¹, M. Gillespie², E. Huang², R. Sandhu²
¹Pathology, Cedars-Sinai Medical Center, Los Angeles, CA, ²Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA
*Purpose: Chronic active T cell-mediated rejection (CACMR) is a newly described variant of kidney allograft rejection associated with long-term graft loss. A key histologic feature…
2020 American Transplant Congress
Simultaneous Laparoscopic Bilateral Native Nephrectomy and Open Kidney Transplantation in Patients with ESRD Due to ADPKD: A Single Center Experience
N. Abrol, A. Bentall, V. Torres, M. Prieto
Mayo Clinic, Rochester, MN
*Purpose: Patients with Autosomal Dominant Polycystic Kidney (ADPKD) progressing to end-stage renal disease (ESRD) often are symptomatic due to cystic kidneys and require surgical intervention.…
2020 American Transplant Congress
Effect of Simultaneous Presence of Anti-Blood Group A/B and -HLA Antibodies on Clinical Outcomes in Kidney Transplantation Across Positive Crossmatch: A Nationwide Cohort Study
H. Kwon, Y. Ko, D. Han
Department of General Surgery, Asan Medical Center, Seoul, Korea, Republic of
*Purpose: ABO-incompatible (ABOi) and positive crossmatch (XM) kidney transplantation (KT) have been considered immunologically challenging. The present study analyzed the clinical outcomes in XM positive…
2020 American Transplant Congress
Impact of Concentrations on Conversion from Twice‑Daily to Once‑Daily Tacrolimus in Stable Kidney Graft Recipients: A Single-Center Retrospective Study
Z. Wang, Y. Cao, Y. Fu
Transplant Surgery, Tianjin First Central Hospital, Tian Jin, China
*Purpose: Potential benefits of once-daily tacrolimus include improved adherence to immunosuppressives and decreased Intrapatient variability (IPV) post kidney transplantation. A retrospective analysis was performed to…
2020 American Transplant Congress
Transient Elastography to Evaluate Steatosis in Candidate Living Donors for Liver Transplantation
E. Palte¹, J. Duong², H. Remotti³, J. Burt³, A. Griesemer⁴, B. Samstein⁵, D. Marratta⁶, A. N. Fox⁷
¹Columbia University Vagelos College of Physicians and Surgeons, New York, NY, ²Columbia University Mailman School of Public Health, New York, NY, ³Department of Pathology and Cell Biology, Columbia University, New York, NY, ⁴Department of Surgery, Columbia University, New York, NY, ⁵Department of Surgery, Weill Cornell Medicine, New York, NY, ⁶Department of Medicine, Columbia University, New York, NY, ⁷Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY
*Purpose: Living donor liver transplantation (LDLT) increases the donor pool and affords a life-saving cure to recipients who do not have MELD-based access to allografts.…
2020 American Transplant Congress
Rare Genetic Mutation Triggering Acute Liver Failure in a Toddler Needing a Liver Transplant
C. B. Chen¹, N. Mistry Ambani¹, A. Zeft¹, R. Garcia-Naviero², V. Hupertz¹, K. Hashimoto¹, K. Radhakrishnan¹
¹Cleveland Clinic, Cleveland, OH, ²Akron Children's Hospital, Akron, OH
*Purpose: The AIRE gene plays an important role in immune tolerance by driving negative selection of self-recognizing T-cells. Mutations in this gene are responsible for…